• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新发2型糖尿病患者心血管事件发生率的时间趋势:一项基于德国人群的队列研究

Time Trends in Cardiovascular Event Incidence in New-Onset Type 2 Diabetes: A Population-Based Cohort Study From Germany.

作者信息

Sarabhai Theresia, Kostev Karel

机构信息

Department of Endocrinology and Diabetology, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine-University, Düsseldorf, Germany.

Epidemiology, IQVIA, Frankfurt am Main, Germany.

出版信息

J Diabetes. 2025 Jun;17(6):e70099. doi: 10.1111/1753-0407.70099.

DOI:10.1111/1753-0407.70099
PMID:40454570
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12127887/
Abstract

BACKGROUND

Events of cardiovascular disease (CVD) remain a critical concern in patients with Type 2 diabetes mellitus (T2D). Over 17 years, this study analyzed time changes in the 5-year incidence of myocardial infarction (MI), chronic coronary heart disease (CHD), transient ischemic attack (TIA), and ischemic stroke (IS).

METHODS

This retrospective cohort study was conducted using the Disease Analyzer database, including patients aged ≥ 18 years with at least 12 months of no prior CVD with new-onset T2D in 2001-2006 (n = 10 162) and in 2013-2018 (n = 30 486), matched 1:3 by age and sex. Kaplan-Meier survival analysis estimated the 5-year cumulative incidence of the outcomes. Multivariable Cox regression models assessed temporal changes, adjusted for comorbidities.

RESULTS

The incidence of CHD and TIA significantly declined in 2013-2018 compared to 2001-2006, with HRs of 0.68 (95% CI: 0.63-0.73; p < 0.001) and 0.63 (95% CI: 0.52-0.76; p < 0.001), respectively. Reductions were more pronounced in women and older patients. Surprisingly, MI incidence showed only a trend of reduction (HR: 0.82; 95% CI: 0.68-0.99; p = 0.045) and IS incidence was not different (HR: 0.97; 95% CI: 0.85-1.12; p = 0.722) between time periods.

CONCLUSIONS

This study is the first to report time trends in CVD incidence in new-onset T2D in Germany. From 2001 to 2018, the 5-year incidence of CHD and TIA decreased in new-onset T2D, reflecting demographic-specific advancements in diabetes and cardiovascular care. However, the stable incidence of IS and MI underscores a persistent challenge in prevention strategies in patients with prediabetes and T2D.

摘要

背景

心血管疾病(CVD)事件仍是2型糖尿病(T2D)患者的关键关注点。在17年的时间里,本研究分析了心肌梗死(MI)、慢性冠心病(CHD)、短暂性脑缺血发作(TIA)和缺血性卒中(IS)5年发病率的时间变化。

方法

本回顾性队列研究使用疾病分析器数据库进行,纳入了年龄≥18岁、在2001 - 2006年(n = 10162)和2013 - 2018年(n = 30486)新诊断为T2D且至少12个月无既往CVD病史的患者,并按年龄和性别1:3进行匹配。Kaplan - Meier生存分析估计了结局的5年累积发病率。多变量Cox回归模型评估了时间变化,并对合并症进行了校正。

结果

与2001 - 2006年相比,2013 - 2018年CHD和TIA的发病率显著下降,风险比(HR)分别为0.68(95%置信区间:0.63 - 0.73;p < 0.001)和0.63(95%置信区间:0.52 - 0.76;p < 0.001)。女性和老年患者的下降更为明显。令人惊讶的是,MI发病率仅呈下降趋势(HR:0.82;95%置信区间:0.68 - 0.99;p = 0.045),且两个时间段之间IS发病率无差异(HR:0.97;95%置信区间:0.85 - 1.12;p = 0.722)。

结论

本研究首次报告了德国新诊断T2D患者CVD发病率的时间趋势。从2001年到2018年,新诊断T2D患者中CHD和TIA的5年发病率下降,反映了糖尿病和心血管护理在特定人群中的进展。然而,IS和MI发病率的稳定凸显了糖尿病前期和T2D患者预防策略中持续存在的挑战。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/619b/12127887/b2f0724df8a7/JDB-17-e70099-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/619b/12127887/6861e71334ea/JDB-17-e70099-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/619b/12127887/b2f0724df8a7/JDB-17-e70099-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/619b/12127887/6861e71334ea/JDB-17-e70099-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/619b/12127887/b2f0724df8a7/JDB-17-e70099-g001.jpg

相似文献

1
Time Trends in Cardiovascular Event Incidence in New-Onset Type 2 Diabetes: A Population-Based Cohort Study From Germany.新发2型糖尿病患者心血管事件发生率的时间趋势:一项基于德国人群的队列研究
J Diabetes. 2025 Jun;17(6):e70099. doi: 10.1111/1753-0407.70099.
2
Coronary artery calcium, hepatic steatosis, and atherosclerotic cardiovascular disease risk in patients with type 2 diabetes mellitus: Results from the Dallas heart study.2 型糖尿病患者的冠状动脉钙、肝脂肪变性和动脉粥样硬化性心血管疾病风险:达拉斯心脏研究的结果。
Prog Cardiovasc Dis. 2023 May-Jun;78:67-73. doi: 10.1016/j.pcad.2023.03.002. Epub 2023 Mar 15.
3
Sex and age significantly modulate cardiovascular disease presentation in type 2 diabetes: a large population-based cohort study.性别和年龄显著调节 2 型糖尿病患者心血管疾病的临床表现:一项大型基于人群的队列研究。
Front Endocrinol (Lausanne). 2024 May 17;15:1344007. doi: 10.3389/fendo.2024.1344007. eCollection 2024.
4
Impact of cardiovascular disease on health care economic burden and resource utilization: a retrospective cohort study in adults in the United States with type 2 diabetes with or without stroke, myocardial infarction, and peripheral arterial disease.心血管疾病对医疗保健经济负担和资源利用的影响:一项针对美国患有或未患有中风、心肌梗死和外周动脉疾病的2型糖尿病成年人的回顾性队列研究。
Curr Med Res Opin. 2022 Nov;38(11):1831-1840. doi: 10.1080/03007995.2022.2125259. Epub 2022 Sep 29.
5
Cardiovascular events and all-cause mortality in a cohort of 57,946 patients with type 2 diabetes: associations with renal function and cardiovascular risk factors.57946例2型糖尿病患者队列中的心血管事件和全因死亡率:与肾功能及心血管危险因素的关联
Cardiovasc Diabetol. 2015 Apr 18;14:38. doi: 10.1186/s12933-015-0204-5.
6
Cardiovascular Risks With SGLT2 Inhibitors in Clinical Practice Among Patients With Type 2 Diabetes.在患有 2 型糖尿病的患者中,临床实践中 SGLT2 抑制剂的心血管风险。
JAMA Netw Open. 2024 Oct 1;7(10):e2441765. doi: 10.1001/jamanetworkopen.2024.41765.
7
Incidence of depression in patients with cardiovascular disease and type 2 diabetes: a nationwide cohort study.心血管疾病和 2 型糖尿病患者的抑郁发生率:一项全国性队列研究。
Clin Res Cardiol. 2024 Nov;113(11):1523-1533. doi: 10.1007/s00392-023-02311-3. Epub 2023 Oct 10.
8
Sex-specific temporal trends in the incidence and prevalence of cardiovascular disease in young adults: a population-based study using UK primary care data.基于英国初级医疗保健数据的研究显示,青年人群中心血管疾病的发病率和患病率存在性别特异性的时间趋势。
Eur J Prev Cardiol. 2022 Aug 5;29(10):1387-1395. doi: 10.1093/eurjpc/zwac024.
9
Cardiovascular risk in mild to moderately decreased glomerular filtration rate, diabetes and coronary heart disease in a southern European region.南欧地区轻度至中度肾小球滤过率降低、糖尿病和冠心病患者的心血管风险
Rev Esp Cardiol (Engl Ed). 2020 Mar;73(3):212-218. doi: 10.1016/j.rec.2018.12.006. Epub 2019 Jan 30.
10
Long-Term Risk of Acute Myocardial Infarction in Patients With a Transient Ischemic Attack: A Danish Nationwide Cohort Study.短暂性脑缺血发作患者急性心肌梗死的长期风险:一项丹麦全国队列研究。
Stroke. 2025 Feb;56(2):478-487. doi: 10.1161/STROKEAHA.123.045605. Epub 2024 Dec 27.

引用本文的文献

1
Comment on "Time Trends in Cardiovascular Event Incidence in New-Onset Type 2 Diabetes: A Population-Based Cohort Study From Germany".对《新发2型糖尿病患者心血管事件发生率的时间趋势:一项基于德国人群的队列研究》的评论
J Diabetes. 2025 Jul;17(7):e70130. doi: 10.1111/1753-0407.70130.

本文引用的文献

1
2-Fold More Cardiovascular Disease Events Decades Before Type 2 Diabetes Diagnosis: A Nationwide Registry Study.2 型糖尿病诊断前数十年心血管疾病事件增加两倍:一项全国登记研究。
J Am Coll Cardiol. 2024 Dec 3;84(23):2251-2259. doi: 10.1016/j.jacc.2024.06.050.
2
Type 2 diabetes incidence in patients initiating denosumab or alendronate treatment: a primary care cohort study.接受地舒单抗或阿仑膦酸钠治疗的患者 2 型糖尿病发病率:一项初级保健队列研究。
Osteoporos Int. 2024 Dec;35(12):2099-2106. doi: 10.1007/s00198-024-07182-6. Epub 2024 Jul 24.
3
The effects of multidisciplinary collaborative care on cardiovascular risk factors among patients with diabetes in primary care settings: A systematic review and meta-analysis.
多学科协作式护理对初级保健环境中糖尿病患者心血管危险因素的影响:系统评价和荟萃分析。
Prim Care Diabetes. 2024 Aug;18(4):381-392. doi: 10.1016/j.pcd.2024.05.003. Epub 2024 Jun 8.
4
10-Year Cardiovascular Risk in Patients With Newly Diagnosed Type 2 Diabetes Mellitus.新诊断 2 型糖尿病患者的 10 年心血管风险。
J Am Coll Cardiol. 2023 Oct 17;82(16):1583-1594. doi: 10.1016/j.jacc.2023.08.015.
5
Cardiovascular disease and risk factors in adults with diabetes mellitus in Hungary: a population-based study.匈牙利成年人糖尿病患者的心血管疾病及危险因素:一项基于人群的研究。
Front Endocrinol (Lausanne). 2023 Sep 14;14:1263365. doi: 10.3389/fendo.2023.1263365. eCollection 2023.
6
GLP-1 Receptor Agonists for the Reduction of Atherosclerotic Cardiovascular Risk in Patients With Type 2 Diabetes.GLP-1 受体激动剂在降低 2 型糖尿病患者的动脉粥样硬化心血管风险中的作用。
Circulation. 2022 Dec 13;146(24):1882-1894. doi: 10.1161/CIRCULATIONAHA.122.059595. Epub 2022 Dec 12.
7
Age-dependent prevalence of type 2 diabetes, cardiovascular risk profiles and use of diabetes drugs in Germany using health claims data.利用健康声明数据分析德国2型糖尿病的年龄依赖性患病率、心血管风险概况及糖尿病药物使用情况
Diabetes Obes Metab. 2023 Mar;25(3):767-775. doi: 10.1111/dom.14924. Epub 2022 Dec 27.
8
Twenty-Year Temporal Trends in Risk of Ischemic Stroke in Incident Type 2 Diabetes: A Danish Population-Based Cohort Study.丹麦基于人群的队列研究:20 年时间内初发 2 型糖尿病患者发生缺血性卒中的风险趋势。
Diabetes Care. 2022 Sep 1;45(9):2144-2151. doi: 10.2337/dc22-0440.
9
Trends in the Incidence of Hospitalization for Major Diabetes-Related Complications in People With Type 1 and Type 2 Diabetes in Australia, 2010-2019.2010 - 2019年澳大利亚1型和2型糖尿病患者重大糖尿病相关并发症住院发生率的趋势
Diabetes Care. 2022 Apr 1;45(4):789-797. doi: 10.2337/dc21-2268.
10
IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045.国际糖尿病联盟(IDF)糖尿病地图集:2021 年全球、区域和国家糖尿病患病率估算值以及 2045 年预测值。
Diabetes Res Clin Pract. 2022 Jan;183:109119. doi: 10.1016/j.diabres.2021.109119. Epub 2021 Dec 6.